NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc. under the Alphalan, Bandrone, Bendit, Bortenat, Clokeran, Desifer, Lenalid, Natdecita, Pomalid, Rasburnat, Thioplan, Veenat, and Xpreza brand names. Its formulations include alprazolam, anastrozole, armodafinil, chloroquine phosphate, oseltamivir phosphate, granisetron, lansoprazole, lansoprazole OTC, letrozole, ondansetron, rizatriptan IR, rizatriptan ODT, trihexyphenidyl, citalopram, zolmitriptan, bendamustine, and imatinib. The company also provides APIs in various categories, such as oncology, central nervous system, pain management, and CV care. In addition, it offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B, as well as is involved in the contract manufacturing activities. Additionally, the company provides cardiology and diabetology products under Bosenat, Ivabratco, Natcocil, and Tenelnat brand names for the treatment of hypertension, stable angina and CHF, pulmonary arterial hypertension, and others. The company markets its products in India and the United States, as well as in Latin America, the Asia Pacific, South East Asia, Europe, and the Middle East. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

868.90 INR
As of 01/24/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  12/31/1999
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   163,910,107,136 INR
Current dividend yield:   0.72%
Sedol:      BZ3D550

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy